Peripheral blood T cell dynamics predict relapse....

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Peripheral blood T cell dynamics predict relapse....

Postby MSUK » Wed Apr 29, 2015 1:41 am

Peripheral blood T cell dynamics predict relapse in MS patients on Fingolimod

Fingolimod efficiently reduces multiple sclerosis (MS) relapse by inhibiting lymphocyte egress from lymph nodes through down-modulation of sphingosine 1-phosphate (S1P) receptors. We aimed to clarify the alterations in peripheral blood T cell subsets associated with MS relapse on fingolimod......... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2876
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service